Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-20T03:28:33.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:57:11.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T01:41:16.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1. This appears to be a minor version update with no impact on the study details or user interactions.
    Difference
    0.0%
    Check dated 2026-02-14T12:43:59.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 in the page header; this is a UI update with no impact on study content or user interactions.
    Difference
    0.0%
    Check dated 2026-02-07T08:39:18.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a glossary display option and updated small text labels (capitalization of QC criteria and FEAR Act data) with the revision bumped to v3.4.0 from v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T04:40:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.